- 全部删除
- 您的购物车当前为空
Galunisertib (LY2157299) 是一种 TGF-β 受体 I 型 (TGF-βRI) 抑制剂 (IC50=56 nM),具有选择性。Galunisertib 具有抗肿瘤活性,可与 PD-1 抑制剂联合治疗。
Galunisertib (LY2157299) 是一种 TGF-β 受体 I 型 (TGF-βRI) 抑制剂 (IC50=56 nM),具有选择性。Galunisertib 具有抗肿瘤活性,可与 PD-1 抑制剂联合治疗。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 210 | In stock | |
2 mg | ¥ 297 | In stock | |
5 mg | ¥ 483 | In stock | |
10 mg | ¥ 732 | In stock | |
25 mg | ¥ 1,330 | In stock | |
50 mg | ¥ 2,320 | In stock | |
100 mg | ¥ 3,230 | In stock | |
200 mg | ¥ 4,680 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 449 | In stock |
Galunisertib 相关产品
产品描述 | Galunisertib (LY2157299) is a TGF-β receptor type I (TGF-βRI) inhibitor (IC50=56 nM) that is selective. Galunisertib has antitumor activity and can be used in combination with PD-1 inhibitors. |
靶点活性 | TβRI:56 nM (cell free), TGFβRII:210 nM, 4T1 cells:> 0.1 μM, HaCaT cells:> 0.1 μM |
体外活性 | 方法: 小鼠胚胎成纤维细胞 NIH3T3 用 Berzosertib (0.0001-10 µM) 处理 2 h,随后用 TGFβ1 孵育过夜,使用 3H-thymidine proliferation assay 检测细胞增殖。 |
体内活性 | 方法: 为检测体内抗肿瘤活性,用 Galunisertib (75 mg/kg,10% beta-cyclodextrin-HCl) 灌胃给药携带 MX1、Calu6 或 4T1 肿瘤的 athymic nu/nu 小鼠,每天两次,持续 20-40 天。 |
激酶实验 | Briefly, the assay was first done at 30°C for 4 h in a 96-well plate containing 2 ng/mL TGF-bR KD, 100 mM Hepes pH 7.5, 4 mM MgCl2, 0.2 mM MnCl2, 0.4 mM sodium orthovanadate, 2 mM DL-dithiothreitol, and 10mM ATP. After incubation, 50mL of Kinase-Glo plus reagent was added and further incubated at 25°C for 30 min. Subsequently, a 100mL aliquot of each reaction mixture was transferred to a black mictotiter plate and the luminescence was measured by a vector counter. The inhibitory activity IC50 was tested in duplicate for each sample [1]. |
细胞实验 | Cell survival was determined using the MTT assay. The conversion of yellow water-soluble tetrazolium MTT into purple insoluble formazan is catalyzed by mitochondrial dehydrogenases and used to estimate the number of viable cells. In brief, cells were seeded in 96-well tissue culture plates at a density of 2 × 103 cells/well. After drug exposure, cells were incubated with 0.4 mg/mL MTT for 4 hours at 37°C. After incubation, the supernatant was discarded, insoluble formazan precipitates were dissolved in 0.1 mL of DMSO, and the absorbance was measured at 560 nm by use of a microplate reader. Wells with untreated cells or with drug-containing medium without cells were used as positive and negative controls respectively. For proliferation assay, MTT assay was done daily to determine the number of viable cells in untreated control and galunisertib-treated group [2]. |
动物实验 | Transgenic mice expressing a fusion gene (Alb/TGF) consisting of modified porcine TGF-β1 cDNA under the control of the regulatory elements of the mouse albumin gene (26) were used under animal institute approved protocol. Mice were given LY-2157299 at a dose of 100mg/kg/day in NaCMC/SLS/PVP/antifoam solution by gastric lavage using a curved 14 G needle. Blood counts were analyzed by the Advia machine. Mice femurs were flushed and bone marrows cells were used for clonogenic assays [3]. |
别名 | LY2157299 |
分子量 | 369.42 |
分子式 | C22H19N5O |
CAS No. | 700874-72-2 |
Smiles | Cc1cccc(n1)-c1nn2CCCc2c1-c1ccnc2ccc(cc12)C(N)=O |
密度 | 1.40 g/cm3 |
颜色 | White |
物理性状 | solid |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 250 mg/mL (676.74 mM), Sonication is recommended. ![]() Ethanol: Insoluble | |||||||||||||||||||||||||||||||||||
体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 6.9 mg/mL (18.68 mM), Solution. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。![]() | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容